The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Holt Matthew S. since year 2005.
The trader's CIK number is 1631836.
At the time of this reporting, Holt Matthew S. is the Director of Bellerophon Therapeutics, Inc. .
(stock ticker symbol BLPH).
See this page for all insider trading activities at Bellerophon Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-02-19||BLPH||Bellerophon Therapeutics, Inc.||Buy||1,070,166||12.00||12,841,992|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Holt Matthew S. (Director of Bellerophon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.